Edition:
United Kingdom

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

13.42USD
17 Jun 2019
Change (% chg)

$0.39 (+2.99%)
Prev Close
$13.03
Open
$13.02
Day's High
$13.42
Day's Low
$12.56
Volume
287,563
Avg. Vol
409,997
52-wk High
$16.46
52-wk Low
$2.76

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.470
FY 2018 Dec '18 0.09 -0.442
Sep '18 0.00 -0.471
Jun '18 0.00 -0.889
Mar '18 0.00 -0.914
FY 2017 Dec '17 0.00 -0.605
Sep '17 0.00 -0.635
Jun '17 0.00 -0.638
Mar '17 0.00 -0.602
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-19 6 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 0.00 0.00 0.00 0.00
Year Ending Dec-20 6 4.33 25.99 0.00 4.06
Earnings (per share)
Quarter Ending Jun-19 6 -0.50 -0.47 -0.53 -0.88
Quarter Ending Sep-19 6 -0.52 -0.48 -0.57 -0.90
Year Ending Dec-19 6 -2.02 -1.84 -2.14 -3.01
Year Ending Dec-20 6 -1.65 -0.24 -2.22 -2.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.12 37.45
P/E High - Last 5 Yrs. -- 165.13 57.55
P/E Low - Last 5 Yrs. -- 52.03 28.57
Beta 4.98 1.18 0.96
Price to Sales (TTM) 3,193.11 42.73 10.02
Price to Book (MRQ) 4.04 12.58 4.53
Price to Tangible Book (MRQ) 4.04 18.14 5.33
Price to Cash Flow (TTM) -- 68.10 26.07
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.61
Dividend Yield - 5 Year Avg -- 0.05 1.35
Dividend 5 Year Growth Rate -- 0.79 6.52
Payout Ratio(TTM) -- 1.51 36.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 61.11 15.38
Sales (TTM) vs TTM 1 Yr. Ago -- 46.83 8.69
Sales - 5 Yr. Growth Rate -38.07 33.28 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.54 -9.16 18.28
EPS (TTM) vs TTM 1 Yr. Ago 18.60 -- --
EPS - 5 Yr. Growth Rate -- 22.24 7.10
Capital Spending - 5 Yr. Growth Rate 154.21 24.81 7.93

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.77 2.47
Current Ratio (MRQ) 9.94 3.76 3.43
LT Debt to Equity (MRQ) 0.00 7.55 14.00
Total Debt to Equity (MRQ) 0.00 20.84 19.69
Interest Coverage (TTM) -- 34.79 15.40

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 26.88 50.06
Gross Margin - 5 Yr. Avg. -- 59.71 51.22
EBITD Margin (TTM) -43,448.61 -- --
EBITD - 5 Yr. Avg -9,669.18 -8.97 16.15
Operating Margin (TTM) -43,567.52 -107.66 -7.35
Operating Margin - 5 Yr. Avg. -9,696.43 -25.48 11.44
Pre-Tax Margin (TTM) -42,734.72 -108.99 -7.82
Pre-Tax Margin - 5 Yr. Avg. -9,603.85 -31.01 16.14
Net Profit Margin (TTM) -42,734.72 -114.67 -11.61
Net Profit Margin - 5 Yr. Avg. -9,603.85 -36.34 11.33
Effective Tax Rate (TTM) -- 17.29 20.12
Effective Tax Rate - 5 Yr. Avg. -- 18.91 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,440 8,835,841 786,836,669
Net Income/Employee (TTM) -1,470,074 1,777,667 92,111,001
Receivable Turnover (TTM) 0.02 11.54 5.85
Inventory Turnover (TTM) -- 2.42 3.71
Asset Turnover (TTM) 0.00 0.33 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.28 6.33 9.71
Return on Assets - 5 Yr. Avg. -58.08 6.22 10.70
Return on Investment (TTM) -61.75 7.69 12.16
Return on Investment - 5 Yr. Avg. -67.45 8.15 13.61
Return on Equity (TTM) -62.10 8.19 16.93
Return on Equity - 5 Yr. Avg. -76.35 9.23 15.13
  1 Year 3 Year 5 Year
Sales % -- -32.44 -38.07
EPS (TTM) % -5.18 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Zynerba Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -15.83 -16.63 52 53
13 Week 162.17 156.32 99 48
26 Week 206.59 176.11 99 36
52 Week 13.30 9.20 99 12
YTD 338.72 280.95 99 11
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 22.84%
# of Holders: 73
Total Shares Held: 4,812,716
3 Mo. Net Change: 1,718,143
# New Positions: 13
# Closed Positions: 16
# Increased Positions: 31
# Reduced Positions: 38
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.